Oerth Bio
New Haven
About Oerth Bio
Oerth Bio is a developer of targeted protein degraders for agricultural applications. The company leverages Arvinas' novel PROTAC protein degrader technology to develop new human therapeutics for patients with cardiovascular, oncological, and gynecological diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $55.0M
- Last round: Corporate Round (Feb 2020)
- Website: oerthbio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/oerth-bio-66120 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.